Objective: The development of antibiotic resistance has recently been recognized as a global health problem. This study was designed to develop new potent molecules that are economic and minimally toxic. The research examined a novel one-step synthetic procedure of bioactive 3-arylazo-substituted coumarin derivatives (4ie4v) and further evaluated their biological actions.
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Abstract
Objective: The development of antibiotic resistance has recently been recognized as a global health problem. This study was designed to develop new potent molecules that are economic and minimally toxic. The research examined a novel one-step synthetic procedure of bioactive 3-arylazo-substituted coumarin derivatives (4ie4v) and further evaluated their biological actions.
Methods: Male and female Wistar rats of appropriate age weighing 180e200 g were used to assess the wound incision, wound excision, acute toxicity and 1,1diphenyl-2-picrylhydrazyl (DPPH) models. The synthesized compounds were structurally interpreted with Differential Screening Calorimetry (DSC), FT/IR, 1H Nuclear Magnetic Resonance (NMR), LC-MS, UV-Visible and elemental analysis. The synthesized compounds were screened to investigate their in vitro antimicrobial, antioxidant and wound healing activities.
Results: A series of 4-hydroxy-3-(arylazo) coumarin (4ie 4v) analogues were synthesized by coupling five different aryl diazonium salts with 4-HC in the presence of a 10% NaOH solution. The majority of the compounds showed significant antimicrobial, wound healing and antioxidant properties. The most potent compounds identified in the analysis were 4iv and 4e.
Conclusion: This study justifies that both aryl and hetero arylazo analogues of 4-hydroxy coumarin possess significant antimicrobial, wound healing and antioxidant properties.
Introduction
C-3 aryl-substituted 4-HC is essential for broad biological actions, such as anti-viral, 1 anti-bacterial, 2 anticancer, 3 anticoagulant 1 and antioxidant 4 activities. Heteroarylazosubstituted compounds have been widely used due to their excellent thermal, 5 optical 6 and biological properties includes antibacterial, 7 antiviral 8 and antioxidant 9 activities. The insertion of an aryl/heteroarylazo moiety at the C-3 position of coumarin has been reported to elicit good antimicrobial activity. 10 The 4-hydroxy 3-heteroaryl coumarin moiety is found in many natural and synthetic products and also exerts significant biological actions. 11 In our earlier work, we have reported the synthesis and characterization of several novel bioactive hetero arylconjugated 4-HC analogues and investigated their antimicrobial activity against four different bacterial pathogens. 12 Subsequently, we evaluated the antimicrobial, wound healing and antioxidant activities of earlier reported molecules as well as those of recently developed new arylconjugated 4-HC analogues against a wide range of bacterial and fungal strains and confirmed their structural characterization.
Materials and Methods
The chemicals used in this study were of synthetic grade and were obtained from Merck specialties Ltd. (Mumbai, India). The synthesized products were structurally confirmed with FT/IR (JASCO FT/IR 4100 Spectrophotometer using KBr disc), 1 H NMR (Bruker H 1 NMR 400 MHZ) using TMS as an internal standard, LC-MS (Shimadzu-Mass spectrometer). differential scanning calorimetry (METTLER TOLEDO STAR e system at a heating rate of 10 C min À1 , temperature range 30e350 C using aluminium cans calibrated with indium) and UV spectrophotometry (JASCO V-630 Spectrophotometer). An elemental analysis was carried out with a Perkin Elmer-2400 CHNO/S analyser system. The melting points were determined with the open capillary method (Elico) and are uncorrected.
4-hydroxy-3-(aryl substituted -2-yldiazenyl)-2H-chromen-2-one (4ie4v) was synthesized as described previously 12 (Figure 1 
4-hydroxy-3-(o-tolyldiazenyl)-2H-chromen-2-one, (4v)
IR (K Br) cm À1 : 3023 (AreH), 2925 (CH 2 str. of CH 3 ), 1709 (C]O str. lactone carbonyl), 1607 (C]C str. of coumarin), 1511 (eN]Ne), 1286 (C-Ostr.), 770 (1, 2 disubst. Ar); 1 H NMR (DMSO-d 6 ) d: 16 .73 (s, 1H, 4-enolic Table 3 .1: Zone of inhibition (mm) of newly synthesized 4-HC aryl and heteroarylazo analogues (4ie4v, 4ae4g) against bacterial strains (Mean ± S.D.). 13 were isolated at the Department of Pharmaceutical Biotechnology, Utkal University. Freshly sub-cultured microorganisms were used. Ampicillin and Fluconazole were used as reference antibiotics.
The antimicrobial activity of the novel 4-HC analogues (4ie4v and earlier reported 4ae4g) was assessed with the well and plate method using molten nutrient agar (antibacterial) and Sabouraud dextrose agar (antifungal). 14 After solidification, the media were inoculated, and 6-mm diameter wells were punched into the media. The wells were filled with a stock solution of test and reference compounds (1 mgmL À1 ) and incubated for 24 h and 72 h for the bacterial and fungal strains, respectively, at 37 C. The diameter of the zone of inhibition was measured using the Hi-Antibiotic Zone Scale.
Determination of minimum inhibitory concentration (MIC) 15
A 1 mgmL À1 stock solution of synthesized compounds and reference antibiotic was prepared in 10% DMF. Furthermore, five different concentrations of (500e 31.25 mgml À1 ) were prepared by serial dilution. The different concentrations of respective compounds were loaded into the wells and incubated at 37 C for 18e24 h. The MIC was determined after incubation.
Pharmacological activity Animals
Male and female Wistar rats of appropriate age weighing 180e200 g were used in this study. The experiments were carried under the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals and approved by the Institutional Animal Ethical Committee with registration number 1171/C/08/CPCSEA and Ref. No. 60/SPS/IAEC/SOAU.
Acute toxicity study
An acute oral toxicity study was performed on female Wistar rats to establish the safe dose of the synthesized compounds. OECD guideline No. 420 (2000) for the Acute Oral Toxicity-Fixed Dose Procedure was followed (sighting study and main study) for a period of 14 days to study the acute toxic symptoms and the behavioural changes of the animals.
Excision wound model
The test compound showing significant antimicrobial activity against a maximum number of bacterial strains was selected for evaluation of wound healing activity. A wound excision model was employed using male Wistar rats to assess the wound healing activity. 16 Group-1 served as the control, group-2 was treated with 2% w/w nitrofurazone cream (standard) and remaining groups (group 3e10) were topically treated with 5% and 10% w/w ointments containing test compounds once per day for 16 days. The area of the wounds was recorded on the 4th, 8th, 12th and 16th day, and the closing percentage and % inhibition were calculated.
Incision wound model
Light incisions were made by cutting the skin of the Wistar rats under mild anaesthesia. 17 The parted skin was stitched together with black silk at both ends of the incisions. The test samples were applied as above. The tensile strength was measured with a tensiometer, 16 days after wounding.
Antioxidant activity assay by DPPH model
The free radical scavenging activity of the novel 4-HC analogues (4ie4v and 4ae4g) was measured using the DPPH method with some modification. 14 The antioxidant activity of synthesized compounds was compared with that of standard butylated hydroxytoluene. The optical density was measured at 517 nm, and the inhibition concentration was calculated. Solution of DPPH in methanol were used as a control.
Statistical analysis
The observed zone of inhibition data were subjected to a one way analysis of variance. The mean zone of inhibition for each compound and each strain was compared with the reference antibiotic with a Dunnett post hoc test. Significance was tested at the 5% level of a type one error. The null hypothesis was a zone of inhibition for the test compound that was larger than that of the reference antibiotic.
Sample size determination
A minimum sample size of five was calculated based on a probability of type 1 error (d) ¼ 0.05, Power (1 À b) ¼ 0.8, Number of groups 13 within group SD ¼ 2. However, a sample size of six was used in the study for each compound and each strain.
Results

Chemistry Spectral analysis
A series of 4-hydroxy-3-(arylazo) coumarin analogues (4ie4v) were synthesized by coupling five different aryl diazonium salts to 4-HC in the presence of a 10% NaOH solution ( Figure 1) . Diazotization was carried out in presences of nitrosyl chloride, and any excess nitrous acid was removed via the addition of urea. The crude products were recrystallized from ethanol. The infrared spectra of the prepared starting material (3) showed a strong absorption band at 3417 cm À1 corresponding to eOH group and band at 1698 cm À1 corresponding to the lactone carbonyl moiety of 4-HC. The involved coupling reactions that initially generated strong aryl diazonium electrophiles from different aryl amines then ultimately coupled at the C-3 position of 4hydroxy coumarin to produce the desired 3-aryl azohydroxy coumarin. The physical data of the prepared compounds are reported in Table 1 .
The infrared spectra of the synthesized compounds (4ie4v, 4ae4g) showed strong absorption bands at 1745e1687 cm À1 , 3555e3446 cm À1 , 1618e1607 cm À1 and 1511e1505 cm À1 due to the presence of lactone carbonyl (C]Ostr), O-Hstr, C] Cstr and eN]N-str functional groups, respectively. This broad value (3555À3446 cm À1 ) reveals that an enolic hydroxyl group was involved due to the intermolecular and intramolecular hydrogen bonding. 14 Compound 4i showed three strong absorption bands at 1695 cm À1 , 1300 and 1137 cm À1 , which were assigned to the stretching of the coumarin lactone carbonyl and the asym/sym stretching of the sulfonyl group, respectively. The medium frequency bands at 1510 and 1280 cm À1 were assigned to (eN]Ne) str and C-Ostr, respectively. Compound 4iv showed four absorption bands at 1742, 1697, 1609 and 1509 cm À1 , which were assigned to the stretching of the carboxylic acid C]O, the carbonyl group of lactone, the C]C str. of coumarin and eN]Ne, respectively. A signal attributable to an aryl amine group was not observed in the 1 H NMR spectral data, and amine absorption bands were also absent in the in FT/IR spectral data for all compounds. All 1 H NMR spectra, except for those of 4i and 4iv, showed board singlet at d 16.73e
16.85 ppm, which suggests the presence of enolic OH in the compounds. For compound 4ii, the proton of the eOCH 3 group was observed in the H 1 NMR at d3.83 ppm as singlet, and the aromatic protons of coumarin were also observed at d 6.94e7.34 ppm as a multiplet (Figure 2 ). In addition, the three medium absorption bands at 2925, 1264 and 1110 cm À1 were assigned to the CH 2 str., ]CeOCH 3 and CeO str. of the methoxy group, respectively. Compound 4i showed two sharp strong vibration bands at 1300 and 1134 cm À1 due to SO 2 asymmetrical and symmetrical stretching, respectively (Figure 3 ). In addition, two series of protons were evident as a multiplet at d 7.75e7.85 and 7.37e 7.81 ppm, which were assigned to the aromatic phenyl protons and coumarin protons, respectively. The predicted molecular weights of synthesized compounds were confirmed by LC-MS and provide strong evidence for the molecular formulas of these compounds. Compounds 4i, 4ii, 4iii, 4iv and 4v had m/z values of 344.96, 296.99, 310.95, 310.33 and 281.13, respectively, which provides strong evidence for the molecular formulas of these compounds. The LC-MS of compound 4iv is given in Figure 4 .
Solvatochromic effect on 4-HC arylazo analogues
The solvent effects of the products were studied by UV-Visible spectrophotometry. The absorption spectra of these compounds (4ie4v) were observed in different solvents at a concentration of 10 À5 to 10 À6 M, and the results are reported in Table 2 . Compound 4ii showed highest bathochromic shift in all solvents with respect to the l max . The l max of compound 4ii was 450 nm in methanol. The solvatochromic effect of 4-HC aryl and hetero aryl analogues in dioxane are reported in Figure 5 . These bathochromic shifts can be attributed to the interaction of the amino protons in the compounds with polar aprotic solvents, such as THF, because the polarity of the dyes generally increases in an excited state. The introduction of an antipyrinyl substituent to the coumarin nucleus at the C-3 position yielded the largest bathochromic shift (l max 447 nm) compared with the other hetero-aryl compounds in all solvents. The presence of a 2-methoxy phenyl (electron donating substituent) moiety in 4ii attached in the same ring system resulted in a bathochromic shift in all solvents compared with the 3-nitro phenyl (electron withdrawing substituent) of 4iv. The l max did not appreciably change for compounds 4i and 4f .
Thermal analysis
The sharp endothermic peak yielded by compound 4i at 207.39 C corresponds to its melting point ( Figure 6 ).
Antimicrobial evaluation
The mean AE SD of the zone of inhibition for the newly synthesized 4-HC aryl and hetero aryl analogues was compared with that of the standard (RA) for each microbial strain with a one way-analysis of variance. The mean zone of inhibition significantly differed by compound, with a p value of 0.00. The pair-wise comparisons of each newly synthesized compound with the standard are expressed as the mean difference AE SEM.
The zones of inhibition were tested against E. coli, S. enterica ser. typhi, S. enterica typhimurium, S. enterica paratyphi, S. flexneri, P. aeruginosa, V. Table 3 .1.
The pair-wise comparisons of each newly synthesized compound with the standard revealed that 4iv and 4e inhibited S. mitis and M. luteus significantly more (p < 0.05) than RA; whereas compound 4iv was significantly more active than RA against B. circulans. Compound 4e showed a significantly larger zone of inhibition than RA against the bacterial strains S. mitis and M. luteus, S. flexneri, K. pneumonia, B. subtilis and S. aureus, as presented in Table 3 .2.
The largest mean zones of inhibition (mm) of compounds 4iv (30.00 AE 1.79), 4iii (18.17 AE 0.41), 4f (24.17 AE 0.75), 4a (18.00 AE 1.27) and 4e (35.00 AE 1.27) were observed against A. niger, T. rubrum, C. albicans, C. glabrata and C. neoformans, respectively, as presented in Table 4 .1.
The pair-wise comparison of each newly synthesized 4-HC analogues with RA revealed that all compounds except 4c and 4d were significantly more active (p < 0.05) against A. niger than RA. Moreover, compounds 4iv, 4e and 4f were significantly more active against the fungal strain C. neoformans than RA, as reported in Table 4 .2.
The zones of inhibition of the 4-HC arylazo analogues against different microorganisms are reported in Figures 7  and 8 , and the significant antimicrobial activity of 4e is graphically presented in Figure 9 .
Evaluation of minimum inhibitory concentration (MIC)
The inhibitory property of the 4-HC analogues was determined in terms of the MIC (mg ml À1 ) ( Table 5 ). The 4-HC analogues 4ii, 4iv, 4b and 4e exhibited potential antibacterial activity at 31.25 mg ml À1 against most bacterial strains. The 4-HC hetero aryl analogue 4e inhibited the growth of twelve pathogens at a concentration of 31.25 mg ml À1 . The 2-methoxy-substituted 4-HC analogue 4ii was the next most potent compound; it inhibited the growth of seven bacterial pathogens at a concentration of 31.25 mg ml À1 . The reference antibiotic (Ampicillin) inhibited all bacterial strains at 31.25 mg ml À1 . Thus, 4e and 4iv may be considered highly effective, and 4v, 4a, 4b and 4f may be considered moderately active compounds, which corroborates the above findings.
Pharmacological evaluations
Acute toxic dose determination
The test compounds were safe at concentrations of up to 2000 mg/kg body weight. No toxic symptoms, gross behavioural changes and mortality were observed. 
Screening of wound healing activity
In the excision wound model, the wounds progressively contracted until the end of observation on the 16th day. Optimum healing was defined as a minimum remaining wound area or % inhibition for the subjected compounds compared with the standard. The compounds included in the experiment showed significant wound healing activity, with more than 80% of wound inhibition by day 16, as reported in Table 6 . The remaining wound areas of the control and standard were 82 AE 4.8 and 40 AE 5.6 mm 2 , respectively with 74.22% and 87.73% inhibition, respectively ( Figure 10) .
The incision study revealed that compounds 4iv, 4a and 4e showed significant breaking strength (force responsible for opening of the closed wound) more than the control ( Table 6 ).
In vitro antioxidant screening
DPPH radicals accept a hydrogen atom or electron from organic molecules and can form stable diamagnetic molecules. The scavenging effects of newly synthesized compounds 4ii, 4iii, 4iv, 4a, 4b, 4c, 4e and 4g as well as that of the butylated hydroxy toluene standard were examined. The 50% of inhibition (IC 50 ) concentrations of the newly synthesized compounds were 50 AE 0.88, 22 AE 0.75, 20 AE 0.5, 30 AE 0.78, 9 AE 0.97, 7 AE 0.84, 9 AE 0.87 and 10 AE 0.94 mg/ml, respectively, whereas that of BHT was 32 AE 0.4 mg/ml (Table 7 ). The antioxidant activities of the synthesized analogues are reported in Figure 11 . The study reveals that the presence of electron withdrawing groups (eCOOH, NO 2 ) increases the antioxidant potential, which may be due to the increase in the positive charge on the enolic hydroxyl group of 4-HC associated with the negative inductive effect of these groups. The positive charge intensification may lead to free radical inhibition. Moreover, the substitution electron-accepting groups are good free radical quenchers. The substitution of an electron-releasing group (eOCH 3 ) was found to decrease the free radical scavenging activity, which may be due to a positive inductive effect.
Discussion
All newly synthesized compounds exhibited good antimicrobial activity against most strains. However, the 4-HC arylazo analogue 4iv exhibited significant antibacterial and antifungal activity, which may be due to nitro substitution. 18 The presence of N-alkyl substituted pyrazolone 4e derived from 4-HC may be responsible for the excellent antimicrobial and antioxidant activity.
Based on the antimicrobial screening, five (4ii, 4iii, 4iv, 4a and 4e) out of twelve (4ie4v, 4ae4g earlier reported) newly synthesized 4-HC analogues showed maximum activity against pathogenic bacterial strains. The wound healing activity of the most potent four compounds (4ii, 4iv, 4a and 4e) was evaluated with an excision and incision model. The reactive oxygen species secreted at wound site are responsible for delayed healing. 19 Moreover, invading microorganisms and free radicals 20 also prevent healing. Antioxidants terminate the formation of free radical intermediates and enable quick recovery of the wound and thus help prevent cell mortality. 21 Our synthesized compounds showed excellent antimicrobial activity and significant antioxidant potential in the wound healing study.
Conclusions
This research details an interesting, easily executed and simple technique for a one step synthesis of coumarin analogues to provide bioactive molecules that inhibit against various pathogens. The synthesized compounds were successfully characterized, and their in vitro antimicrobial and antioxidant activities were explored such that they can be used as ligands for new azo-metal complexes.
